Coliseum Capital, LLC 4
Research Summary
AI-generated summary
Universal Technical Institute (UTI) Director Coliseum Capital Sells 3M Shares
What Happened Coliseum Capital Management, LLC (an entity reported as a director-affiliated filer) sold 3,000,000 shares of Universal Technical Institute, Inc. (UTI) in an open-market sale on 2026-06-08 at $41.40 per share, generating proceeds of $124,200,000. The filing notes that the shares are held by Coliseum Capital Partners, L.P. (CCP) and a Separate Account advised by Coliseum Capital Management; Christopher Shackelton — who is a director of UTI — is a manager of the adviser and related entities.
Key Details
- Transaction date and price: 2026-06-08, sale of 3,000,000 shares at $41.40 each (total ≈ $124,200,000).
- Shares owned after transaction: CCP holds 801,777 shares and the Separate Account holds 169,663 shares (total reported remaining = 971,440 shares).
- Filing: Form 4 covering the 6/8 transaction was filed 2026-06-10 (appears timely under Section 16 reporting rules).
- Footnotes: F1–F3 explain the shares are held by CCP and a Separate Account advised by Coliseum Capital Management; Shackelton and Adam Gray are managers with ownership interests in the adviser and related entities and disclaim beneficial ownership except for pecuniary interest.
- Remarks: The filing notes Shackelton is a director and that CCM, CC, CCP and Gray may be deemed directors for Section 16 deputization purposes.
Context This was an institutional/open-market sale by entities affiliated with a director, not a direct purchase by the company insider as a personal buy. Sales by investment-adviser-controlled accounts can be routine portfolio management and do not necessarily reflect the director’s personal trading intent. Purchases typically carry more direct signals of insider confidence than sales, which are often diversification or liquidity events.